| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.43 | 0.1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |